Real-time enrollment status for this pten-altered advanced solid tumors and her2 negative breast cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:14 PM UTC
| NCT Number | NCT04997993 |
| Recruiting Status | Recruiting |
| Condition | PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 23 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Deborah Doroshow |
| Last Updated on CT.gov | June 15, 2026 (4 weeks ago) |
As of July 13, 2026: Clinical trial NCT04997993 is currently recruiting participants. This clinical trial study for pten-altered advanced solid tumors and her2 negative breast cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Deborah Doroshow. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04997993 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04997993 was last updated 4 weeks ago (June 15, 2026). HelloStudys verifies this status automatically.